4//SEC Filing
AbbVie Inc. 4
Accession 0001179110-17-002810
$ABBVCIK 0001551152operating
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 5:51 PM ET
Size
11.1 KB
Accession
0001179110-17-002810
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
HURWICH THOMAS A.
VP, Controller
Transactions
- Award
Common stock, $0.01 par value
2017-02-16+5,612→ 67,061 total - Award
Option (right to buy)
2017-02-16+13,050→ 13,050 totalExercise: $61.36From: 2018-02-16Exp: 2027-02-15→ Common shares (13,050 underlying) - Award
Common stock, $0.01 par value
2017-02-16+2,526→ 69,587 total
Holdings
- 274(indirect: By Spouse)
Common stock, $0.01 par value
- 447(indirect: By Trust)
Common stock, $0.01 par value
Footnotes (5)
- [F1]Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017.
- [F2]Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017.
- [F3]Balance in the AbbVie Savings Program as of February 16, 2017.
- [F4]The reporting person disclaims beneficial ownership of all securities held by his spouse.
- [F5]Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 4,350 on 02/16/2018, 4,350 on 02/16/2019, and 4,350 on 02/16/2020.
Documents
Issuer
AbbVie Inc.
CIK 0001551152
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001551152
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 5:51 PM ET
- Size
- 11.1 KB